share_log

BRIEF-NRX Pharmaceuticals Entered Into Shareholder Agreement With Shimshon Hen And David Sepiashvili

BRIEF-NRX Pharmaceuticals Entered Into Shareholder Agreement With Shimshon Hen And David Sepiashvili

簡介-NRX製藥公司與Shimshon Hen和David Sepiashvili達成股東協議
reuters ·  2021/10/21 17:33

Oct 21 (Reuters) - NRX Pharmaceuticals Inc NRXP.O :

路透10月21日電-NRX製藥公司NRXP.O：

* NRX PHARMACEUTICALS INC - ENTERED INTO A SHAREHOLDER AGREEMENT WITH SHIMSHON HEN AND DAVID SEPIASHVILI

*NRX製藥公司-與Shimshon Hen和David Sepiashvili達成股東協議

* NRX PHARMACEUTICALS INC - AGREEMENT FOR NEW JV BETWEEN CO AND SHAREHOLDERS FOR DEVELOPMENT AND COMMERCIALIZATION OF BRILIFE VACCINE

*NRX製藥公司-CO和股東就BRILIFE疫苗的開發和商業化達成的新合資企業協議

* NRX PHARMACEUTICALS INC - AGREEMENT PROVIDES THAT COMPANY WILL HOLD 60% OF EQUITY INTEREST IN VACCINECO WITH SHAREHOLDERS HOLDING REMAINING 40%

*NRX製藥公司-協議規定，公司將持有VACCINECO 60%的股權，股東持有剩餘的40%

* NRX PHARMACEUTICALS INC - VACCINECO EXPECTED TO HAVE A FOUR-MEMBER BOARD OF DIRECTORS, CO & SHAREHOLDERS WILL EACH BE ENTITLED TO APPOINT 2 MEMBERS

*NRX製藥公司-VACCINECO預計將有一個四人董事會，CO和股東每人將有權任命2名成員

Source text for Eikon: [ Further company coverage: NRXP.O

Eikon的源文本：[進一步的公司報道：NRXP.O

((Reuters.Briefs@thomsonreuters.com;))

(Reurs.Briefs@thomsonreurs.com；)

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論